Skip to main content

CA Healthcare Acquisition Corp. (CAHC)

NASDAQ: CAHC · Delayed Price · USD
10.79
+0.74 (7.36%)
Pre-market:Sep 27, 2021 5:49 AM EDT
10.05
0.05 (0.50%)
At close: Sep 24, 4:00 PM
Market Cap173.36M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out14.38M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume822,772
Open10.00
Previous Close10.00
Day's Range9.67 - 10.80
52-Week Range9.55 - 10.80
Betan/a
Analystsn/a
Price Target14.75 (+46.8%)
Est. Earnings Daten/a

About CAHC

CA Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. CA Healthcare Acquisition Corp. was founded in 2020 and is based in Boston, Massachusetts.

IndustryShell Companies
IPO DateJan 27, 2021
Stock ExchangeNASDAQ
Ticker SymbolCAHC
Full Company Profile

News

CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 2...

BOSTON--(BUSINESS WIRE)--CA Healthcare and LumiraDx Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination

2 weeks ago - Business Wire

LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation ...

BOSTON & LONDON--(BUSINESS WIRE)--LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics

1 month ago - Business Wire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contac...

NEW YORK, April 29, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Mountain Crest Acquisition Corp. II (NASDAQ: MCAD)  c...

Other symbols:LATNMCADMUDSROT
4 months ago - PRNewsWire

Covid Testing Company LumiraDx Goes Public in SPAC

Apr.07 -- LumiraDx Ltd., a diagnostic company that produces Covid-19 tests, is going public through a reverse merger with a blank-check company.

5 months ago - Bloomberg Markets and Finance

LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare...

BOSTON & LONDON--(BUSINESS WIRE)--LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp

5 months ago - Business Wire

CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing M...

BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 9, 2021

6 months ago - Business Wire

CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering

BOSTON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp. Announces Closing of $115,000,000 Initial Public Offering

7 months ago - Business Wire

Healthcare SPAC CA Healthcare Acquisition files for a $100 million IPO

CA Healthcare Acquisition, a blank check company targeting the healthcare industry, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

8 months ago - NASDAQ

CA Healthcare Acquisition IPO Registration Document (S-1)

CA Healthcare Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

8 months ago - SEC